Defective splicing of the background K+ channel K2P5.1 by the pre-mRNA splicing inhibitor, pladienolide B in lectin-activated mouse splenic CD4+ T cells by Kazutaka Tagishi, Ayaka Shimizu, Kyoko Endo, Hiroaki Kito, Satomi Niwa, Masanori Fujii, Susumu Ohya

Subjects: Get full text

Pre-mRNA splicing-associated diseases and therapies by Sierra L. Love, Joseph D. Emerson, Kazunori Koide, Aaron A. Hoskins

Subjects: Get full text

Spliceostatin C, a component of a microbial bioherbicide, is a potent phytotoxin that inhibits the spliceosome by Joanna Bajsa-Hirschel, Zhiqiang Pan, Pankaj Pandey, Ratnakar N. Asolkar, Amar G. Chittiboyina, Louis Boddy, Marylou C. Machingura, Stephen O. Duke

Subjects: Get full text

Splicing targeting drugs highlight intron retention as an actionable vulnerability in advanced prostate cancer by Chiara Naro, Ambra Antonioni, Vanessa Medici, Cinzia Caggiano, Ariane Jolly, Pierre de la Grange, Pamela Bielli, Maria Paola Paronetto, Claudio Sette

Subjects: Get full text

Targeting the CLK2/SRSF9 splicing axis in prostate cancer leads to decreased ARV7 expression by Jasper Van Goubergen, Miroslav Peřina, Florian Handle, Elisa Morales, Anika Kremer, Oliver Schmidt, Glen Kristiansen, Marcus V. Cronauer, Frédéric R. Santer

Subjects: Get full text